Searched for
TRADING MARGIN EXCESS
Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...- Why cheap stocks offer more safety than strong inflows, says Sundaram AMC MDTwo years ago, seasoned asset manager Anand Radhakrishnan moved from a long, successful stint as Chief Investment Officer (CIO) at Franklin...
- Enough of COP JamboreesFalling solar and battery costs have made renewable energy commercially competitive with coal in India. As COP31 begins in Turkiye, the foc...
- Sensex, Nifty end Muhurat Trading session in red for first time in 9 years. Are the bulls losing steam?Sensex and Nifty erased all early gains and closed in the red following the Muhurat Trading session on Sunday, marking the first time the b...
- PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horsesHDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 20...
- Diwali 2026 wealth creators: 8 BSE 500 stocks shrug off market weakness, deliver up to 191% returns; do you own any?Eight BSE 500 stocks more than doubled investors’ wealth since Diwali 2025, led by Aditya Infotech, HFCL and Welspun Corp. As Samvat 2083 b...
- Investors in other markets would be envious of India multiples: Rich Handler, chief executive of JefferiesJefferies CEO Rich Handler believes Indian equities remain reasonably valued despite the market correction and says easing long-term capita...
- Scrap, cut or tweak? Centre weighs options on LTCG, STT to stem foreign investor exodusThe Centre is weighing proposals to scrap or lower long-term capital gains tax and recalibrate securities transaction tax as it seeks to ad...
- US tariffs squeeze Canadian cabinet makers facing doubling of Trump dutyAs US tariffs on Canadian kitchen cabinets are set to double to 50%, the industry faces significant challenges. Companies like Cabico are c...
- Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...
- Why traders are moving away from equity F&O to commodities? Nithin Kamath explainsCommodity derivatives traders in India surged nearly 62% to 21 lakh in FY26, while equity F&O participants fell 20% to 85 lakh. Zerodha's N...
- Rs. 15 lakh crore of revenue, questioned by authorities – and the real worry was where the cash wentA company can report a loan, an advance, or an investment even after the cash has moved beyond its control. Sometimes the explanation is le...
- Global Market: European automakers get earnings boost as Chinese competition weighs on recoveryEuropean automakers have received a boost from recent earnings, but their recovery remains fragile. Rising competition from Chinese manufac...
- Diwali blues: 83 largecap stocks plunge up to 60% since Samvat 2082. Can bluechips light up D-Street in the new year?Indian equities enter Samvat 2083 after a volatile year and a sharp market correction. While lower valuations have improved the risk-reward...
- NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...
- The Rs 1.5 lakh crore MTF problem: How shrinking leveraged positions are deepening India's smallcap sell-offIndia’s smallcap sell-off is intensifying as margin trading facility (MTF) positions decline from record levels. With nearly Rs 72,000 cror...
- M&M Financial Services shares crash 10% after Q2 results. What are Nomura and other analysts saying?Mahindra & Mahindra Financial Services shares fell sharply on despite a 55% year-on-year rise in Q2FY27 net profit to Rs 882 crore. Nomura ...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
Load More
